StockData
USANA Health Sciences Inc logo

USANA Health Sciences Inc (USNA) stock

USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.22−0.35 (-2.58%)

Close on Nov 18, 2026Market cap $244.26MP/E –Yield –

USANA Health Sciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

USANA Health Sciences's revenue for the twelve months ending Jul 4, 2026 was $913.36M, up 1.6% year over year. For fiscal 2025 it was $925.26M, up 8.3% from the year before. Over ten years it grew 0.1% a year on average. The highest annual figure on record is $1.19B in fiscal 2018.

Annual revenue

PeriodPeriod endValueChange
FY2025Jan 3, 2026$925.26M+8.3%
FY2024Dec 28, 2024$854.50M-7.2%
FY2023Dec 30, 2023$921.01M-7.8%
FY2022Dec 31, 2022$998.60M-15.8%
FY2021Jan 1, 2022$1.19B+4.6%
FY2020Jan 2, 2021$1.13B+7.0%
FY2019Dec 28, 2019$1.06B-10.8%
FY2018Dec 29, 2018$1.19B+13.6%
FY2017Dec 30, 2017$1.05B+4.1%
FY2016Dec 31, 2016$1.01B+9.5%
FY2015Jan 2, 2016$918.50M+16.2%
FY2014Jan 3, 2015$790.47M+10.1%
FY2013Dec 28, 2013$718.18M+10.7%
FY2012Dec 29, 2012$648.73M+11.5%
FY2011Dec 31, 2011$581.94M+12.4%
FY2010Jan 1, 2011$517.64M+18.5%
FY2009Jan 2, 2010$436.94M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jul 4, 2026$223.27M-5.3%
Q1 FY2026Apr 4, 2026$250.22M+0.3%
Q4 FY2025Jan 3, 2026$226.20M+5.9%
Q3 FY2025Sep 27, 2025$213.67M+6.7%
Q2 FY2025Jun 28, 2025$235.85M+10.8%
Q1 FY2025Mar 29, 2025$249.54M+9.5%
Q4 FY2024Dec 28, 2024$213.61M-3.4%
Q3 FY2024Sep 28, 2024$200.22M-6.2%
Q2 FY2024Jun 29, 2024$212.87M-10.6%
Q1 FY2024Mar 30, 2024$227.80M-8.3%
Q4 FY2023Dec 30, 2023$221.08M-3.0%
Q3 FY2023Sep 30, 2023$213.37M-8.5%
Q2 FY2023Jul 1, 2023$238.20M-9.9%
Q1 FY2023Apr 1, 2023$248.36M-9.0%
Q4 FY2022Dec 31, 2022$227.96M-14.7%
Q3 FY2022Oct 1, 2022$233.30M-15.0%
Q2 FY2022Jul 2, 2022$264.47M-21.5%
Q1 FY2022Apr 2, 2022$272.87M-11.4%
Q4 FY2021Jan 1, 2022$267.30M-13.9%
Q3 FY2021Oct 2, 2021$274.35M-8.1%
Q2 FY2021Jul 3, 2021$336.84M+30.1%
Q1 FY2021Apr 3, 2021$307.98M+15.5%
Q4 FY2020Jan 2, 2021$310.52M+14.5%
Q3 FY2020Sep 26, 2020$298.51M+14.5%
Q2 FY2020Jun 27, 2020$258.99M+1.2%
Q1 FY2020Mar 28, 2020$266.62M-2.3%
Q4 FY2019Dec 28, 2019$271.30M-9.3%
Q3 FY2019Sep 28, 2019$260.60M-12.2%
Q2 FY2019Jun 29, 2019$256.02M-15.1%
Q1 FY2019Mar 30, 2019$272.99M-6.5%
Q4 FY2018Dec 29, 2018$299.02M+9.5%
Q3 FY2018Sep 29, 2018$296.77M+13.4%
Q2 FY2018Jun 30, 2018$301.46M+17.3%
Q1 FY2018Mar 31, 2018$292.00M+14.4%
Q4 FY2017Dec 30, 2017$273.11M+8.0%
Q3 FY2017Sep 30, 2017$261.77M+3.0%
Q2 FY2017Jul 1, 2017$257.06M–
Q1 FY2017Apr 1, 2017$255.32M–
Q4 FY2016Dec 31, 2016$252.90M–
Q3 FY2016Oct 1, 2016$254.22M–

More USANA Health Sciences figures

See a number that looks wrong?